Previous studies have revealed that GTSE1 could promote the malignant progression of tumors in lung cancer, colon cancer, and liver cancer (Zheng et al., 2019; Zhang F. et al., 2021; Li, 2021). Here, GTSE1 is linked to liver cancer.